Intensity Therapeutics, Common Stock Year To Date Return
| INTS Stock | 2.21 0.01 0.45% |
Intensity Therapeutics, Common fundamentals help investors to digest information that contributes to Intensity Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Intensity Stock. The fundamental analysis module provides a way to measure Intensity Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intensity Therapeutics, stock.
Intensity | Year To Date Return |
Intensity Therapeutics, Common Company Year To Date Return Analysis
Intensity Therapeutics,'s Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Intensity Year To Date Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Intensity Therapeutics, is extremely important. It helps to project a fair market value of Intensity Stock properly, considering its historical fundamentals such as Year To Date Return. Since Intensity Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Intensity Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Intensity Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
| Competition |
Intensity Return On Tangible Assets
Return On Tangible Assets |
|
According to the company's disclosures, Intensity Therapeutics, Common has a Year To Date Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Intensity Year To Date Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intensity Therapeutics,'s direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intensity Therapeutics, could also be used in its relative valuation, which is a method of valuing Intensity Therapeutics, by comparing valuation metrics of similar companies.Intensity Therapeutics, is currently under evaluation in year to date return category among its peers.
Intensity Therapeutics, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intensity Therapeutics, from analyzing Intensity Therapeutics,'s financial statements. These drivers represent accounts that assess Intensity Therapeutics,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intensity Therapeutics,'s important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 69.3M | 75.9M | 81.3M | 65.4M | 75.3M | 80.6M |
Intensity Therapeutics, ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Intensity Therapeutics,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Intensity Therapeutics,'s managers, analysts, and investors.Environmental | Governance | Social |
Intensity Fundamentals
| Return On Equity | -1.47 | ||||
| Return On Asset | -0.73 | ||||
| Current Valuation | 30.74 M | ||||
| Shares Outstanding | 15.1 M | ||||
| Shares Owned By Insiders | 47.16 % | ||||
| Shares Owned By Institutions | 12.48 % | ||||
| Number Of Shares Shorted | 59.39 K | ||||
| Price To Book | 12.01 X | ||||
| EBITDA | (10.09 M) | ||||
| Net Income | (10.54 M) | ||||
| Total Debt | 158 K | ||||
| Book Value Per Share | 0.96 X | ||||
| Cash Flow From Operations | (7.21 M) | ||||
| Short Ratio | 3.05 X | ||||
| Earnings Per Share | (1.07) X | ||||
| Target Price | 10.0 | ||||
| Market Capitalization | 33.38 M | ||||
| Total Asset | 17.3 M | ||||
| Retained Earnings | (50.52 M) | ||||
| Working Capital | 11.51 M | ||||
| Net Asset | 17.3 M |
About Intensity Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intensity Therapeutics, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intensity Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intensity Therapeutics, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics,'s price analysis, check to measure Intensity Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics, is operating at the current time. Most of Intensity Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics,'s price. Additionally, you may evaluate how the addition of Intensity Therapeutics, to your portfolios can decrease your overall portfolio volatility.